Catalyst Wire Dossier Catalyst Wire Dossier

Quadrivalent Subunit Influenza Vaccine (Adjuvant)

· Ab&B Bio-tech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent Subunit Influenza Vaccine (Adjuvant), covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older [Phase 1]

See pricing